Group One Trading’s Soleno Therapeutics SLNO Stock Holding History

Group One Trading’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Buy	64,700 +16,800	+35%	+$659K	﹤0.01%	2002
2025 Q4	$2.22M	Buy	47,900 +19,200	+67%	+$1.05M	﹤0.01%	2200
2025 Q3	$1.94M	Buy	28,700 +8,300	+41%	+$615K	﹤0.01%	2344
2025 Q2	$1.71M	Buy	20,400 +8,400	+70%	+$629K	﹤0.01%	2285
2025 Q1	$857K	Sell	12,000 -90,300	-88%	-$4.4M	﹤0.01%	2597
2024 Q4	$4.6M	Buy	+102,300	New	+$5.3M	0.01%	1228
2022 Q1	–	Sell	-407	Closed	-$3K	–	8647
2021 Q4	$3K	Sell	407 -720	-64%	-$7.55K	﹤0.01%	7808
2021 Q3	$16K	Sell	1,127 -193	-15%	-$2.69K	﹤0.01%	7297
2021 Q2	$23K	Buy	1,320 +367	+39%	+$6.2K	﹤0.01%	7105
2021 Q1	$18K	Buy	953 +680	+249%	+$21.9K	﹤0.01%	6810
2020 Q4	$8K	Buy	+273	New	+$7.88K	﹤0.01%	5879

Other funds holding SLNO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Group One Trading's SLNO Position: Q1 2026 in Review

Group One Trading reduced its Soleno Therapeutics (SLNO) stake by 11% in Q1 2026, selling an estimated $101K and leaving 19,953 shares worth $668K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

Group One Trading first reported a position in SLNO in Q3 2020 and has held it in 19 quarters since. The position peaked at $1.04M in Q4 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

Group One Trading held 19,953 shares of Soleno Therapeutics worth $668K as of Q1 2026.
Group One Trading sold 2,577 Soleno Therapeutics shares in Q1 2026, an estimated $101K.
Soleno Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3072 holding.
Group One Trading first reported a position in Soleno Therapeutics in Q3 2020 and has held it in 19 quarters since.
Group One Trading's Soleno Therapeutics position peaked at $1.04M in Q4 2025.
225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.